Piperacillin–Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?

Numerous observational studies and meta-analyses have suggested that combination therapy consisting of piperacillin–tazobactam (TZP) and vancomycin (VAN) augments acute kidney injury (AKI) risk when compared to viable alternatives, such as cefepime–vancomycin (FEP–VAN) and meropenem–VAN. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslan, Abdullah Tarık, Akova, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407917/
https://www.ncbi.nlm.nih.gov/pubmed/36011239
http://dx.doi.org/10.3390/healthcare10081582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407917/
https://www.ncbi.nlm.nih.gov/pubmed/36011239
http://dx.doi.org/10.3390/healthcare10081582

Ejemplares similares